Medicamen Biotech Limited (NSE:MEDICAMEQ)

Medicamen Biotech Revenue

Medicamen Biotech had revenue of 487.59M INR in the quarter ending June 30, 2026, with 12.05% growth. This brings the company's revenue in the last twelve months to 2.06B, up 22.21% year-over-year. In the fiscal year ending March 31, 2026, Medicamen Biotech had annual revenue of 1.98B with 18.04% growth.

• Revenue (ttm): 2.06B
• Revenue Growth: +22.21%
• P/S Ratio: 2.13
• Revenue / Employee: 5.09M
• Employees: 405
• Market Cap: 4.39B

Revenue Chart

Chart

Chart

Revenue History

Fiscal Year End	Revenue	Change	Growth
Mar 31, 2026	1.98B	302.23M	18.04%
Mar 31, 2025	1.68B	-117.59M	-6.56%
Mar 31, 2024	1.79B	384.39M	27.29%
Mar 31, 2023	1.41B	254.22M	22.02%
Mar 31, 2022	1.15B	27.29M	2.42%

Data Source: S&P Global Market Intelligence Last updated: Aug 14, 2026

Revenue data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Sep 20, 2026

Data Sources Report a data error